Interferon Alpha and Cytosine Arabinoside in the Treatment of Chronic Myelogenous Leukemia

[1]  P. Cony-Makhoul,et al.  Response to recombinant interferon alpha in patients with chronic myelogenous leukemia in a single center: results and analysis of predictive factors. , 1995, Leukemia.

[2]  S. Richards,et al.  UK Medical Research Council randomised, multicentre trial of interferon-αn1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic response , 1995, The Lancet.

[3]  H. Kantarjian,et al.  Prolonged Survival in Chronic Myelogenous Leukemia after Cytogenetic Response to Interferon- Therapy , 1995, Annals of Internal Medicine.

[4]  S. Cannistra,et al.  Hematologic remission and cytogenetic improvement after treatment of stable‐phase chronic myelogenous leukemia with continuous infusion of low‐dose cytarabine , 1993, American journal of hematology.

[5]  R. Kurzrock,et al.  Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia. Philadelphia chromosome-positive patients. , 1991, Annals of internal medicine.

[6]  C. Slapak,et al.  Interferon protects normal human granulocyte/macrophage colony-forming cells from Ara-C cytotoxicity. , 1990, Journal of biological response modifiers.

[7]  H. Kantarjian,et al.  Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemia. , 1986, The New England journal of medicine.

[8]  J. Griffin,et al.  Clinical pharmacology of low-dose cytosine arabinoside , 1985 .

[9]  S. Sallan,et al.  Pharmacokinetics of continuous intravenous and subcutaneous infusions of cytosine arabinoside. , 1982, Blood.

[10]  A. Efira,et al.  Sensitivity of myeloid progenitor cells in healthy subjects and patients with chronic myeloid leukemia to chemotherapeutic agents. , 1981, Journal of the National Cancer Institute.

[11]  J. Huret,et al.  Cytogenetic Remissions in Chronic Myelogenous Leukemia Using Interferon Alpha-2a and Hydroxyurea with or without Low-Dose Cytosine Arabinoside. , 1991, Leukemia & lymphoma.

[12]  S. Bigner,et al.  Evidence for a selective antileukemic effect of cytosine arabinoside in chronic granulocytic leukemia. , 1988, Leukemia research.

[13]  S. Leong,et al.  Preferential inhibition by cytarabine of CFU‐GM from patients with chronic granulocytic leukemia , 1987, Cancer.